← All Sponsors
SPONSOR

Kymera Therapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Eosinophilic Asthma
NCT07323654 Phase 2
Recruiting

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Eosinophilic Asthma
United States View Trial →